The UCSF “D’Vice Squad,” a group of innovators from across the Bay Area, has drawn from diverse disciplines over the last two years to develop medical devices for children.  

The University of California has begun work to deploy an integrated payroll and human resource system across all 10 campuses and five medical centers to streamline business operations and save money.

An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.